×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: pfizer | biontech | 3.2 billion vaccine deal with u.s. government

Pfizer Signs $3.2B COVID Vax Deal With US

Pfizer Signs $3.2B COVID Vax Deal With US
(AP)

Wednesday, 29 June 2022 05:05 PM EDT

Pfizer Inc. and BioNTech said Wednesday they had signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine for delivery as soon as late summer this year.

The deal also includes an omicron-adapted vaccine, pending regulatory clearance, Pfizer said.

Advisers to the U.S. Food and Drug Administration on Tuesday recommended a change in the design of COVID-19 booster shots this fall in order to combat more recently circulating variants of the coronavirus.

The U.S. government also has the option to purchase up to 195 million additional doses, bringing the total number of potential doses to 300 million, the companies said.

© 2022 Thomson/Reuters. All rights reserved.


StreetTalk
Pfizer Inc. and BioNTech said Wednesday they had signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine for delivery as soon as late summer this year.
pfizer, biontech, 3.2 billion vaccine deal with u.s. government
107
2022-05-29
Wednesday, 29 June 2022 05:05 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved